Downregulation of PI3K/AKT/mTOR Pathway in Juglone-Treated Bovine Oocytes.

El-Sheikh, Marwa; Mesalam, Ayman; Khalil, Atif Ali Khan; Idrees, Muhammad; Ahn, Mi-Jeong; Mesalam, Ahmed Atef; Kong, Il-Keun

El-Sheikh, Marwa; Mesalam, Ayman; Khalil, Atif Ali Khan; Idrees, Muhammad; Ahn, Mi-Jeong; Mesalam, Ahmed Atef; Kong, Il-Keun.

Afiliación

El-Sheikh M; Department of Microbial Biotechnology, Biotechnology Research Institute, National Research Centre (NRC), Dokki, Cairo 12622, Egypt.
Mesalam A; Department of Theriogenology, Faculty of Veterinary Medicine, Zagazig University, Zagazig 44519, Egypt.
Khalil AAK; Department of Pharmacognosy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University, Lahore 54000, Pakistan.
Idrees M; Division of Applied Life Science (BK21 Four), Gyeongsang National University, Jinju 52828, Republic of Korea.
Ahn MJ; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju 52828, Republic of Korea.
Mesalam AA; Department of Therapeutic Chemistry, Pharmaceutical and Drug Industries Research Institute, National Research Centre (NRC), Dokki, Cairo 12622, Egypt.
Kong IK; Division of Applied Life Science (BK21 Four), Gyeongsang National University, Jinju 52828, Republic of Korea.

Antioxidants (Basel) ; 12(1)2023 Jan 03.

Article en En | MEDLINE | ID: mdl-36670976

Palabras clave

AKT; PI3K; histone methylation; juglone; mTOR; oocyte quality; signaling

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Antioxidants (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Egipto